Pharmaceutical

DMTs are major clinical research focus for Parkinson’s disease, analysis shows

GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's disease treatments.

Nov 13, 2024 - 06:00
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's disease treatments.
Read the original article

Tags:

Previous Article

Are dry powder inhalers the key to sustainable respiratory care?

Next Article

Uppsala and KTH Royal develop antibody for potential cancer treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

eGenesis scoops $191m for genetically modified pig kidney transplant trial

eGenesis scoops $191m for genetically modified pig kidn...

Sep 6, 2024

STAT+: Pharmalittle: Pharma hopes reformulated drugs will skirt Medicare negotiations; Biogen to acquire Reata for $7.3 billion

STAT+: Pharmalittle: Pharma hopes reformulated drugs wi...

Jul 28, 2023

Mobile health strategies: Should you build or partner for success?

Mobile health strategies: Should you build or partner f...

Sep 27, 2023